Avista Healthcare
Avista to leverage expertise in the healthcare technology sector and dental end-market to support Spear’s growth ambitions NEW YORK, Dec. 19, 2022 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced its acquisition of Spear Education (“Spear” or the “Company”), a tech-enabled provider of digital and in-person […]
Effective January 1, 2023, Bekki Brown will assume the role of President & Chief Executive Officer of UBC BLUE BELL, P.A., November 10, 2022 – UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, announced today that effective January 1, 2023, Bekki Brown, UBC’s Chief Operating Officer, will be elevated to the role […]
Leading Antibody Discovery Technologies Enable Development of Innovative Therapeutics Regular-way Trading of OABI Begins November 2, 2022 on Nasdaq EMERYVILLE, Calif. (November 1, 2022) – OmniAb, Inc. (NASDAQ: OABI) today announced the completion of the expected tax-free spin-off from Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and the subsequent business combination with Avista Public Acquisition Corp. II […]
Avista to leverage industry expertise to support Taconic’s growth in the large and expanding GEMs market NEW YORK, November 1, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced its acquisition of Taconic Biosciences (“Taconic” or the “Company”), a leading provider of genetically engineered research models (GEMs) and related […]
Extraordinary General Meeting of APAC Shareholders to Vote on Proposed Business Combination with OmniAb to be Held on October 24, 2022 NEW YORK (October 3, 2022) – Avista Public Acquisition Corp. II (NASDAQ: AHPA) (“APAC”) announced today the effectiveness of the Registration Statement on Form S-4 filed with the Securities and Exchange Commission (the “SEC”) in […]
About the Acquisition Vision Healthcare reached an agreement with the shareholders of AixSwiss BV for the acquisition of 100% of the shares in AixSwiss BV (“AixSwiss” or the “Company”), a leading DACH e-commerce player active in probiotic nutraceutical supplements commercialised under the “Nupure” brand mainly through its own e-store, Amazon and e-pharma channels. AixSwiss was […]
Combination establishes a one-stop shop for efficient end-to-end solutions that facilitate chemical compound procurement and management for highly specialized chemists SAN DIEGO and NEWARK, Del., Sept. 7, 2022 /PRNewswire/ — eMolecules, Inc., provider of a leading chemistry search-and-fulfillment platform for early drug discovery research, today announced the acquisitions of Frontier Scientific Inc. (FSI) and Frontier Agricultural Sciences […]
Avista to leverage its expertise and resources to accelerate WellSpring’s growth trajectory for the benefit of all stakeholders NEW YORK, August 23, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the completion of its acquisition of WellSpring Consumer Healthcare (“WellSpring”), a developer and marketer of leading over-the-counter (“OTC”) […]
TAMPA, Fla.– Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair, and service, announced the acquisition of Mi Healthcare. Terms of the transaction were not disclosed. Established in 1995, Mi Healthcare is a Liverpool, United Kingdom-based provider of medical imaging equipment and services to public and private healthcare facilities across the […]
BRIDGEWATER, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, today announced that it has entered into arrangements to secure up to $68.9 million in committed financing through a combination of equity and non-dilutive […]
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry BLUE BELL, Pa., July 28, 2022 /PRNewswire/ — UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, today announced that it has acquired Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) company. Examoto is dedicated […]
First Ever Phase 3 Program to Show Improvement in Both Symptoms and Inflammation Inside the Sinuses with a Nasal Therapy for Chronic Sinusitis Patients Physicians Diagnose Chronic Sinusitis 10 Times More Frequently Than XHANCE’s Current Nasal Polyps Indication and there is no FDA-Approved Medication for these Patients Conference call and webcast to be held today at 8:30 a.m. […]